It causes joint inflammation and stiffness, leading to pain and limited mobility. While medical treatments and medications can help manage the symptoms, adopting an anti-inflammatory diet can be a ...

Joint pain is a common symptom we all experience at some point or another. Painful joints can have a significant impact on ...

Stem cell therapy is emerging as a promising solution for joint pain, offering regeneration and long-term relief by ...

This treatment effect lessened during the 1-year follow-up ... For example, while the TREAT EARLIER trial recruited patients with joint pain and subclinical joint inflammation via MRI, regardless of ...

Biologic response modifiers, which are based on proteins made by living cells, are newer agents available for the treatment of various inflammatory joint diseases. Biologic therapies now approved ...

Prescription doses can help curb joint inflammation ... the joints in people with certain forms of inflammatory arthritis. Aggressive treatment of arthritis often involves using one or more ...

Researchers employed analysis tools and machine learning algorithms to identify two genes linked to rheumatoid arthritis and osteoporosis that could serve as diagnostic tools and potential targets for ...

Future studies are needed to evaluate the potential use of specific α7nAChR agonists for the treatment of ... the production of inflammatory cytokines present in the joint. It seems likely ...

Two "key" genes have been identified by scientists linking the painful condition and the bone disease osteoporosis.

Tumour Necrosis Factor TNF is crucial for defence but can drive chronic inflammation linked to arthritis and autoimmune diseases when overproduced ...

Rheumatoid arthritis is a common disease affecting an estimated 17 million people worldwide. The disease is caused by immune cells attacking the joints and can result in pain, swelling, and damage to ...

In a world first, researchers at the Kennedy Institute, Oxford have mapped the cellular dynamics following treatment with the ...